TrialClinical cancer research : an official journal of the American Association for Cancer Research2025

Phase II Open-Label Trial of Brentuximab Vedotin with Pembrolizumab in PD-1-Pretreated Metastatic Non-Small Cell Lung Cancer and Metastatic Cutaneous Melanoma.

Sylvia M Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.